Clinical Trials
2 trialsNCT04918186 2026-05-12
IPROC
Canadian Cancer Trials Group
Phase 2 Recruiting
NCT05342506 2022-04-22
Clinical Study on the Safety, Pharmacokinetics, and Efficacy of ScTIL (Genetically Modified Tumor Infiltrating Lymphocytes) in the Treatment of Gynecological Malignancies
Peking Union Medical College Hospital
Phase 2 Unknown